Onfi
Brand for: Clobazam
My Prescription
Payment
Select pharmacy
$30.77
Print or send this coupon to your phone
CVSPowered byAbout Onfi
Drug Details
Clobazam, known under the brand name Onfi, is a medication used to manage seizures in individuals who are 2 years of age and older, specifically those with Lennox-Gastaut syndrome (LGS). This drug is categorized as a benzodiazepine and works by enhancing the activity of gamma-aminobutyric acid (GABA), a natural chemical in the brain. By boosting GABA, clobazam exerts a calming effect on the brain, which helps reduce seizure occurrences. The medication is intended to be used alongside other anti-seizure drugs and is available in both generic tablet and oral liquid forms, typically taken twice daily. Common side effects may include drowsiness, fever, and vomiting. Always consult with a healthcare professional before starting any new medication.
Price history for Onfi (brand) & Clobazam (generic)
60 Tablets, 10MG
Average retail price for Onfi
Average retail price for Clobazam
Average SaveHealth price for Clobazam
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
Over the last 12 months, the average discount price of Onfi is $32.65 using the SaveHealth savings card. That's an average savings of 98.98% on Onfi with our discount card.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Onfi (Clobazam) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 10MG | 60 Tablets | $30.77 | $0.51 |
| 10MG | 1 Tablet | $14.35 | $14.35 |
| 10MG | 30 Tablets | $24.31 | $0.81 |
| 10MG | 100 Tablets | $41.38 | $0.41 |
| 20MG | 60 Tablets | $35.85 | $0.60 |
| 20MG | 100 Tablets | $52.22 | $0.52 |
Onfi FAQs
Onfi is used as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome, a severe form of epilepsy, in patients two years of age and older.
Onfi (clobazam) is primarily prescribed for the treatment of seizures associated with Lennox-Gastaut syndrome, a form of epilepsy. While it is a benzodiazepine and may have some anxiolytic effects, it is not typically used as a first-line treatment for anxiety disorders. Patients should consult their healthcare provider for appropriate treatment options for anxiety.
Onfi (clobazam) is classified as a controlled substance because it is a benzodiazepine, which has the potential for abuse, dependence, and addiction. Benzodiazepines can produce sedative effects and are often used to treat anxiety and seizure disorders, but their potential for misuse necessitates regulation under controlled substance laws to ensure safe and appropriate use.
Clobazam is classified as a controlled substance because it is a benzodiazepine, which has the potential for abuse, dependence, and misuse. These properties necessitate regulation to prevent inappropriate use and ensure it is prescribed and dispensed safely.
Common side effects of Onfi (clobazam) may include drowsiness, lethargy, drooling, constipation, cough, fever, and irritability. Some individuals may also experience more serious side effects such as mood changes, difficulty breathing, or signs of an allergic reaction. It is important for patients to discuss any side effects they experience with their healthcare provider.